Natalizumab improves disability on the Multiple Sclerosis Functional Composite in a randomised, double-blind, placebo-controlled study of patients with relapsing multiple sclerosis

被引：0
|
作者：
Munschauer, F.
Giovannoni, G.
O'Connor, P. W.
Phillips, J. T.
Polman, C. H.
Pace, A.
Hyde, R.
Kim, R.
机构：
[1] Jacobs Neurol Inst, Buffalo, NY USA
[2] Barts & London Queen Marys Sch Med & Dent, London, England
[3] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[4] Multiple Sclerosis Ctr Texas Neurol, Dallas, TX USA
[5] VU Med Ctr, Amsterdam, Netherlands
[6] Biogen Idec Inc, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS | 2009年 / 15卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S124 / S125
页数：2
相关论文
共 50 条
  • [1] A randomised, double-blind, placebo-controlled study of fluoxetine for relapsing multiple sclerosis
    Mostert, I. P.
    Admilaal-Behlou, E.
    Hoogduin, I. M.
    Luyetidijk, J.
    Heersema, D. J.
    van Buchem, M. A.
    de Keyser, J.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S25 - S26
  • [2] Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
    Ebers, GC
    Rice, G
    Lesaux, J
    Paty, D
    Oger, J
    Li, DKB
    Beall, S
    Devonshire, V
    Hashimoto, S
    Hooge, J
    Kastrukoff, L
    Krieger, C
    Mezei, M
    Seland, P
    Vorobeychi, G
    Morrison, W
    Nelson, J
    Freedman, MS
    Chrisie, S
    Nelson, R
    Rabinovitch, H
    Freedman, C
    Hartung, HP
    Rieckmann, P
    Archelos, J
    Jung, S
    Weilbach, F
    Flachenecke, P
    Sauer, J
    Hommes, O
    Jongen, P
    Brouwer, S
    McLeod, J
    Pollard, J
    Ng, R
    Sandberg-Wollheim, M
    Källén, K
    Nilsson, P
    Ekberg, R
    Lundgren, A
    Jadbäck, G
    Wikström, J
    Multanen, J
    Valjakka, M
    Carton, H
    Lissoir, F
    Declerq, I
    Vieren, M
    Peeters, E
    Dubois, B
    [J]. LANCET, 1998, 352 (9139): : 1498 - 1504
  • [3] Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trial
    Miller, David H.
    Weber, Thomas
    Grove, Richard
    Wardell, Claire
    Horrigan, Joseph
    Graff, Ole
    Atkinson, Gillian
    Dua, Pinky
    Yousry, Tarek
    MacManus, David
    Montalban, Xavier
    [J]. LANCET NEUROLOGY, 2012, 11 (02): : 131 - 139
  • [4] A randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis
    Baumhackl, U
    Kappos, L
    Radue, EW
    Freitag, P
    Guseo, A
    Daumer, M
    Mertin, J
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 166 - 168
  • [5] Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
    Confavreux, Christian
    O'Connor, Paul
    Comi, Giancarlo
    Freedman, Mark S.
    Miller, Aaron E.
    Olsson, Tomas P.
    Wolinsky, Jerry S.
    Bagulho, Teresa
    Delhay, Jean-Luc
    Dukovic, Deborah
    Truffinet, Philippe
    Kappos, Ludwig
    [J]. LANCET NEUROLOGY, 2014, 13 (03): : 247 - 256
  • [6] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
    Polman, CH
    O'Connor, PW
    Havrdova, E
    Hutchinson, M
    Kappos, L
    Miller, DH
    Phillips, JT
    Lublin, FD
    Giovannoni, G
    Wajgt, A
    Toal, M
    Lynn, F
    Panzara, MA
    Sandrock, AW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09): : 899 - 910
  • [7] Natalizumab improves physical disability in patients with relapsing multiple sclerosis
    Giovannoni, G.
    Munschauer, F.
    O'Connor, P. W.
    Phillips, J. T.
    Polman, C. H.
    Pace, A.
    Kim, R.
    Panzara, M. A.
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S124 - S124
  • [8] Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
    Hartung, HP
    Gonsette, R
    König, N
    Kwiecinski, H
    Guseo, A
    Morrissey, SP
    Krapf, H
    Zwingers, T
    [J]. LANCET, 2002, 360 (9350): : 2018 - 2025
  • [9] Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study
    Mostert, J. P.
    Admiraal-Behloul, F.
    Hoogduin, J. M.
    Luyendijk, J.
    Heersema, D. J.
    van Buchem, M. A.
    De Keyser, J.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (09): : 1027 - 1031
  • [10] A double-blind, placebo-controlled, multicentre study to evaluate dirucotide in relapsing-remitting multiple sclerosis
    Selmaj, K.
    Verco, T.
    Ossanna, M.
    Nilsson, M.
    Ferenczi, L.
    Chappell, A.
    Arfors, L.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S235 - S235
12345